Jul 9, 2026
China Updates National Essential Medicines List for First Time in Eight Years, Adding Semaglutide and 115 Other Drugs as Domestic Oral GLP-1 Treatments Show Progress
On July 9, 2026, China's National Health Commission added injectable semaglutide and 115 other drugs to its National Essential Medicines List — the first update in eight years — expanding the catalog to 794 medicines effective September 1, 2026, while domestic oral GLP-1 candidates from Hengrui and Gan & Lee advanced in clinical trials.
5 sources
00